The U.S. Citizenship and Immigration Services has issued an interim final rule establishing a framework for requiring certain immigration benefit requests to be filed electronically. The rule, published on August 11, 2026,
Sandoz, the generics and biosimilars spinout of Novartis, has struck a pair of settlement agreements to resolve long-running antitrust litigation brought by US state and federal enforcers. The company announced it had
More
Missouri Solicitor General Louis Capozzi has built one of the state’s most powerful litigation operations in under a year, compiling a strong record across election law, constitutional litigation, and consumer protection. Appointed
More
The deans of all three Washington state law schools are calling on the Washington Supreme Court to grant diploma privilege to hundreds of affected graduates. The push follows the chaotic cancellation of
More
Wall Street edged closer to record territory on Monday as investor sentiment improved following reports that Iran and the United States were engaged in active diplomatic talks. President Donald Trump claimed that
More
AstraZeneca, one of the FTSE 100’s most heavily weighted constituents, saw its shares fall as reports emerged of potential tie-up talks with Bristol Myers Squibb. The drag from AstraZeneca was enough to
More
Amgen has disclosed a significant cybersecurity breach in which hackers stole sensitive patient health information and proprietary company data from its cloud systems. The California-based drugmaker identified unauthorised activity within cloud storage
More
The U.S. Court of Appeals for the Seventh Circuit has upheld a Wisconsin health system’s overtime calculation practices, finding them consistent with both federal and state wage law. The ruling came in
More
Before joining the highest court in the land, Byron White was, for a remarkable stretch, the most dominant running back in professional football. White, nicknamed “Whizzer,” first made his name as a
More
The FTSE 100 closed in negative territory on Monday, weighed down by a sharp decline in pharmaceutical giant AstraZeneca following reports of a potential mega-merger. The FTSE 100 index ended the session
More
The question of whether equity markets are overvalued has become one of the most debated topics among investors and analysts navigating a complex economic landscape in 2026. Stock market valuations have been
More